Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Trent , David Agus , Mari Baker, David Brailer, John Doerr, Dana Mead, Sue Siegel, Carlos Camargo, Daniel Federman, Bruce Landon, Redonda Miller, Michael Nierenberg, David Botstein, Isaac Kohane, Nicholas Schork, Dietrich Stephan, Peggy Conrad, El

Premium
Navigenics said last week that it has formed its board of directors and advisory boards. Jeffrey Trent, president and scientific director of the Translational Genomics Research Institute in Arizona, chairs Navigenics’ scientific advisory board.
 
The board of directors includes David Agus, a company cofounder and research director of the Louis Warschaw Prostate Cancer Center; Mari Baker, Navigenics’ president and CEO; David Brailer, chairman of Health Evolution Partners; John Doerr, a partner of Kleiner Perkins Caufield and Byers; Dana Mead, also a partner of Kleiner Perkins Caufield and Byers; and Sue Siegel, a partner of Mohr Davidow Ventures and former president of Affymetrix.
 
Additional members of the clinical advisory board are Carlos Camargo, emeritus clinical professor of medicine at Stanford University; Daniel Federman, professor of medicine at Harvard Medical School; Bruce Landon, associate professor of healthcare at Harvard Medical School; Redonda Miller, associate professor of medicine at Johns Hopkins University; and Michael Nierenberg, medical director of Navigenics.
 
Other SAB members are David Botstein, professor of genomics at Princeton University; Isaac Kohane, professor of pediatrics and health sciences as well as health sciences and technology at Harvard Medical School; Nicholas Schork, director of research at Scripps Genomic Medicine; and Dietrich Stephan, cofounder and chief science officer of Navigenics.
 
Peggy Conrad,a practicing genetic counselor for more than a decade, is the chair of Navigenics’ genetic counseling task force. Elissa Levin, genetics counseling program director at Navigenics; and Kelly Ormond, associate professor of genetics at Stanford, are members of this task force.
 
Greg Simon, chairing the policy and ethics task force, is president of FasterCures-The Center for Accelerating Medical Solutions. Task force member include: Rachel Grob, associate dean of graduate studies at Sarah Lawrence College; Kathi Hanna, a biomedical research policy analyst; and Paul Slovic, founder and president of Decision Research.
 

 
Former Biotechnology Industry Organization director of government relations Barrett Thornhill has joined the law firm of Foley Hoag LLP as a health policy specialist in its Washington, DC, office. Before handling legislative efforts at BIO, Thornhill was a health policy legislative assistant for Senator Mike Crapo and worked with other US representatives.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.